SCHEMBL25720108

SCHEMBL25720108

COc1c(C(=O)Nc2ccncc2)c(=O)n(-c2ccccc2)c2ccccc12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 1/20 0.51
ALOX15 P16050 1/20 0.51
HIF1A Q16665 1/20 0.49
LMNA P02545 3/20 0.48
PKM P14618 1/20 0.48
HTT P42858 5/20 0.47
ALDH1A1 P00352 4/20 0.47
TOP2A P11388 2/20 0.46
MEN1 O00255 3/20 0.45
KMT2A Q03164 3/20 0.45
EGFR P00533 2/20 0.45
SRC P12931 2/20 0.45
FGFR1 P11362 1/20 0.45
RECQL P46063 1/20 0.44
NPC1 O15118 1/20 0.43
KDM4E B2RXH2 2/20 0.43
RIPK1 Q13546 1/20 0.43
HPGD P15428 1/20 0.43
GAA P10253 1/20 0.42
MAPT P10636 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25720105 0.89 LMNA (0.49) LMNAPKMHTTALDH1A1TOP2A
SCHEMBL25722544 0.89 HIF1A (0.49) HSP90AA1ALOX15HIF1ALMNAHTT
SCHEMBL24054661 0.84 HIF1A (0.67) HSP90AA1ALOX15HIF1ALMNAHTT
SCHEMBL25720179 0.81 HSP90AA1 (0.77) HSP90AA1ALOX15HIF1ALMNAHTT
SCHEMBL10675833 0.79 SRC (0.62) ALOX15LMNAHTTALDH1A1MEN1
SCHEMBL25722535 0.79 LMNA (0.49) HIF1ALMNAPKMHTTALDH1A1
SCHEMBL25720110 0.79 KMT2A (0.53) LMNAPKMHTTTOP2AMEN1
SCHEMBL10674496 0.78 KMT2A (0.67) HSP90AA1ALOX15HIF1AHTTALDH1A1
SCHEMBL8171372 0.77 TOP2A (0.54) HTTALDH1A1TOP2AMEN1KMT2A
SCHEMBL25720116 0.76 EGFR (0.49) TOP2AKMT2AEGFRSRCMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230203003-A1 Notch Inhibitors and Uses Thereof STEMSYNERGY THERAPEUTICS, INC. 2023-06-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230203003-A1 Notch Inhibitors and Uses Thereof NOTCH1, NOTCH2, NOTCH4 HSP90AA1 4749/4885ALOX15 1130/4885HIF1A 1418/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.